Research shows that over 60% of cast-treated pets get additional injures, such as pressure sores, from traditional plaster casts1.
The new cast is designed to tackle these issues with anatomically shaped bi-valve splints that are based on 30,000 3D scans of animal limbs.
Upets TLC products are made from FDA and CE approved Woodcast material used in human casting and splinting.
Bandages, padding and tape are replaced with a soft, self-cohesive Unitex fabric that passes moisture and dries fast.
TLC products are engineered for easy destabilisation by removing parts of the splint, and the same product can be used throughout the whole treatment.
Orthopets, a subsidiary of the materials company Dassiet, says that breathable, lightweight materials combined with the anatomical fit help prevent sores and restore normal position and movement of the limb.
OrthoPets founder Martin Kaufmann said: “The common cast is very problematic, but we've lacked better alternatives. Now, with the Dassiet supermaterials and OrthoPets’ vast experience in veterinary biomechanics we have re-engineered the common cast.
"Upets TLC is anatomical and safe. It’s stress-free for both the vet and the pet. It brings veterinary casting to the modern day and offers a better standard care option for all vets and orthopaedic surgeons out there.”
"Sores, pain and stiffness are always on the horizon with casting. But if we take the cast off too early, the leg can be injured again because of lack of proper support. UPETS tackles these problems all at once. I find it easy to apply the pre-shaped casts even for very small or large dogs and make adjustments if needed. I can watch my patients walk off the clinic normally with their cast, knowing they can wear it safely until fully healed. We see significant and immediate improvement in patients compared to the common cast”, says Dassiet Chief Veterinarian Jouni Niemi, who oversees the clinical research of UPETS.
For more information, visit: www.upets.vet/TLC
Reference
Henry, who works at Crowshall Veterinary Services in Norfolk, graduated from the Royal Veterinary College in 2018.
He is the lead products export vet for Crowshall and was instrumental in the business’s preparation for Brexit.
He is also one of the founding ‘green champions’ at the practice, which has become the first specialist poultry practice to be accredited with Investors in the Environment.
The panel of seven judges from said that within just three years Henry has gained much experience, showing evidence that he has contributed to reduced antibiotic usage as well as improved biosecurity and improved bird welfare, health and production for his clients.
They said: “He has clearly shown he has worked with colleagues as a team, and has introduced new initiatives in his practice including improving mental health of staff and assisting in sustainability.”
James Porritt, National Pig and Poultry Sales Manager of award sponsors Zoetis, said all three finalists were very strong candidates: “It was great to see the work they have all done recognised at the awards.
"It was fantastic to see Henry win and hope the award spurs him on to continue his bright future in the poultry industry.”
Photo: Henry Lamb holding the Young Farm Vet trophy, alongside Jonathan Agnew (left) and James Porritt of the award sponsors Zoetis
Buprecare is indicated for post-operative analgesia and the potentiation of the sedative effects of centrally-acting agents in dogs, as well as post-operative analgesia in cats.
It is presented in a 10 ml multi-use bottle.
Animalcare Product Manager Eleanor Workman Wright said: "Buprenorphine is a potent, high affinity, synthetic opioid.
"It plays a central role in many practice anaesthesia protocols so we are delighted to announce that it is back in stock."
For more information, contact your Animalcare Territory Manager or contact Animalcare’s head office on 01904 487687.
The service uses an Xstrahl 100 superficial radiotherapy system, a £150,000 piece of equipment installed by Paragon after it was used successfully in the USA by the hospital's medical and radiation oncology specialist, Dr Rodney Ayl.
Rodney (pictured right) says the new equipment will transform the way Paragon can treat skin cancers, dermatological disorders and some other common superficial conditions.
He said: “This is a very exciting development for us and our clients because Xstrahl systems have been used so successfully in human medicine for many years.
“This prompted us to explore adapting the SRT system for veterinary use in the UK and we hope to collaborate with Colorado State University, which has a similar unit, to develop protocols for pets.
“We believe this will be a significant advance in the treatment and care of animals and we’re delighted to be at the forefront of introducing this new service.
“It is the only one of its kind for pets in the UK and there are very few units like this anywhere in the veterinary industry, so it really is an important move forward.”
Xstrahl radiotherapy systems were originally designed for the treatment of skin cancer, dermatological disorders, certain types of benign disease and some palliative care in humans.
Rodney says that having adapted the SRT system for animals will transform their treatment and the logistics and cost of getting radiation therapy for superficial skin conditions.
He added: “Superficial radiotherapy is particularly useful for treating some types of skin cancer where it may be preferable to surgery as it can deliver excellent non-invasive outcomes with curative or palliative intent.
“The treatment is less stressful from the outset and, thanks to its mechanism of action, it is also pain-free.
“Its use of different size cones, directly over the lesion, minimises effects on healthy skin and the fast treatment means a large reduction in time and impact on the patient’s day-to-day life, while providing a highly-effective treatment.
“The machine’s flexibility also makes it particularly suited for treating multiple lesions that are difficult to access, such as the head and neck, without changing patient positioning.
“The Xstrahl 100 system will help us to respond to the growing demand for radiation treatment and we can treat these patients on an outpatient basis, helping us to reduce surgical and hospitalisation costs.
“The technology is a real winner. It is easy to use and helps us to deliver safe and effective radiotherapy to our animal patients.
“It provides a quicker, easier, cheaper and non-invasive alternative for superficial tumours, especially in geriatric patients where surgery is not always an option. We’re looking forward to seeing the positive results here at Paragon.”
For more information, visit www.paragonreferrals.co.uk.
Carbodote Prime is the first activated charcoal product for cats and dogs to contain a cathartic, which speeds up intestinal transit time so that bound toxins are expelled more quickly.
Carbodote Repeat is for those situations where repeated administration of plain activated charcoal is needed due to the type of the toxin involved.
Carbodote Repeat can be administered to the patient every 4-6 hours over 24-48 hours.
Both products are presented as a ready-mixed, easy to swallow gel formulation, for less mess and reduced risk of aspiration.
TVM says the 60ml ‘dial and dispense’ syringes make administration easy for both veterinary staff and pet owners.
For more information, visit www.tvm-uk.com/carbodote or contact your Territory Manager.
John graduated from the RVC in 1973, after which his first job was at a mixed, mainly farm animal practice in Gloucestershire.
From there he moved to a mixed equine/small animal practice in Maidstone before joining Pierson Stewart and Partners, of which he later became a partner and then sole owner. He sold the business in 2018.
John has lectured widely in veterinary dentistry, practice management and cardiology.
He continues to see cardiac cases and carry out breed heart certification.
John invented the word autobiology as it seemed befitting of a life in which animals and plants have been so intricately tied to his work as a veterinary surgeon and his hobbies of gardening and lawn tennis.
He said: "I hope anyone in the profession who is interested in the history of veterinary medicine will enjoy reading how much things have changed in the last 50 years.
"It also has something for anyone interested in practice management, business and finance, not to mention sport.
"I hope it might also help everyone think about their work life balance and mental well being.
"Or you might just enjoy the funny and sometimes tear-jerking anecdotes."
Autobiology of a Vet is priced at £15.99 (hardback) / £8.99 (paperback) / £6.99 (ebook).
For more information, visit: https://www.gbpublishing.co.uk/autobiology-of-a-vet
The company has been gathering information on the health, wellbeing and life expectancy of hundreds of thousands of dogs since 2014.
Sean McCormack (pictured right), Head Vet at tails.com, said: “As a vet in practice, you gain an understanding of general animal issues and trends. But what this data can do is look over hundreds of thousands of dogs, unpick all of the nutritional, breed and age-related data we’ve collected over time, and then provide an insight-rich window into the best possible way to care for our dogs.
“We’re really just scratching the surface in terms of what we have at our disposal. There’s real potential for Data Labs to fundamentally change the way that we view dog nutrition and dog health going forwards.”
According to the company, the database has already revealed that:
Lorna Brightmore, Lead Data Scientist at tails.com, said: "Even at this early stage, we are finding strong associations between a number of health factors and longevity and our conclusions will only become stronger over time.”
The first major milestone of Data Labs will be the publication of tails.com’s first peer-reviewed scientific paper.
The paper will detail the effects of body weight, body condition, gender and neutering on the longevity and health of dogs, with further scientific papers planned for publication in the coming months and years.
For more information, visit www.tails.com/gb/data-labs/.
Methadyne can be administered for analgesia of moderate to severe pain in dogs and cats, to provide neuroleptanalgesia in combination with a neuroleptic drug and as part of a patient’s premedication protocol prior to general anaesthesia.
The new presentation will now be available alongside the 10ml vial to give greater flexibility and to help reduce drug wastage and streamline controlled drug stock management.
Jurox says Methadyne has proven compatibility when combined in the same syringe with other aqueous solutions for injection containing acepromazine as maleate and medetomidine and dexmedetomidine as hydrochlorides.
Methadyne has a shelf life of 24 months unbroached, and 28 days broached. After broaching, the bung can be punctured to draw up a dose of methadone as many times as required in 28 days.
Dan Cripwell MRCVS, senior veterinary technical advisor at Jurox (UK) Limited, said: “I am delighted that Jurox can provide the UK veterinary market with this evolution in our multidose methadone formulation, which is now available in both 5ml and 10ml vials.
"We constantly strive to provide the veterinary profession with first class clinical and technical support and, in this instance, we were able to assess what improvements could be made to our existing drug portfolio and respond to the profession’s feedback to help reduce wastage of controlled drugs when they are needed in smaller volume."
For further information, contact your local Jurox account manager, phone 0800 500 3171, visit www.jurox.com/uk or email customerservice@jurox.co.uk.
Head nurse Nicola Atkins (pictured right) said: “We are very happy and proud to have achieved our silver accreditation for cat-friendly clinic status.
“To earn this internationally-recognised award, we had to prove that we met all of the ISFM criteria, including allocating a nurse and vet at each centre who are dedicated to caring for our cats and providing ‘cat only’ waiting areas to reduce their stress.”
“We provide cats with carefully-tailored care from our stress-free waiting areas and high standards of anaesthetic protocols, which deliver an enriched stay at our hospitals.
“This also reassures owners and makes them feel more at ease about visiting our clinics with their cats.”
For more information, visit www.veterinaryvision.co.uk.
The dispensation was brought in during the spring 2020 lockdown to safeguard animal health and welfare, the health & safety of the veterinary team, and public health, by allowing prescriptions to be made by veterinary surgeons without having first physically examined the animal.
Since it was brought in, the temporary dispensation has been under constant review and, in September, was extended to midnight on Sunday 31st October 2021.
Last week, the Standards Committee met and decided to end the dispensation, although it has put back the end date for the guidance to midnight on Sunday 21 November to allow sufficient time for veterinary practices to change their protocols and policies accordingly.
Melissa Donald, RCVS Junior Vice-President and Chair of the Standards Committee, said: “Due to a number of factors, including evidence that there has been a decline in the amount of remote prescriptions taking place, the Committee took the decision to end the dispensation, albeit with a three-week extension period to allow those practices that are still prescribing remotely to change their policies, inform their clients and so on.
“While the dispensation is ending, it is worth noting that it will still be kept under review in light of any changes in the circumstances around the pandemic, including government advice and regulations.”
The full details about the temporary dispensation can be found at: www.rcvs.org.uk/coronavirus.
Those with any questions about the guidance should contact the RCVS Standards & Advice Team on advice@rcvs.org.uk or 020 7202 0789.
The practice has been leading research into the devastating disease since 2012 and has collated information on all confirmed cases across the country.
The disease, which originally appeared in the late 1980s, was first detected in the UK in 2012.
When it affects the kidneys, it has a 90% mortality rate.
The new site offers advice and information, including a live map of confirmed cases across the UK, for both vets and pet owners.
David Walker, American, RCVS and EBVS European specialist in small animal internal medicine, leads the team at Anderson Moores and is the UK’s foremost authority on the disease.
He said: “We have been at the forefront of research into CRGV for almost a decade now and have witnessed first-hand the often-devastating effects of the disease.
“In launching this new website, we aim to inform pet owners and colleagues in the veterinary industry about CRGV.
“We hope the confirmed case map will prove useful.
"Although an environmental trigger has not been definitively proven, the seasonality of the disease makes it eminently possible and the map allows everyone to see the location of confirmed cases.”
So far this year, Anderson Moores has recorded a total of 26 confirmed cases of CRGV.
This number comes on the back of 47 confirmed cases during 2020, 19 cases in 2019 and 18 in 2018.
277 cases have been confirmed since the disease was first recognised in the UK in 2012.
David said: “As we enter the winter months, we want to advise dog owners around the country to remain calm but vigilant and seek advice from their local vets if their dog develops an unexplained skin lesion(s), especially on the leg.
“Unfortunately, we find ourselves in the time of year when cases are most commonly identified – 92% of dogs with the disease are seen between November and May.
"This is understandably a concern for dog owners; however, the disease remains rare.
“If a dog is suspected to be suffering from CRGV, the best chance of recovery probably lies with early and intensive management which may be best provided at a specialist facility.
“Treatment primarily revolves around intensive management of the acute kidney injury and is sadly only successful in around 10% cent of cases.”
Visit https://www.alabama-rot.co.uk .
Delivered in a case-based style, the course will give students the chance to work through cases and apply practical theory before treating feline patients.
There are four modules: the consultation, further investigations, treatment, and post-operative and preventative care.
ICC says the emphasis is on providing practical skills that can be used in clinic.
On completion, students will have the confidence to identify a range of dental abnormalities, persuade cat owners to consent to further investigation and treatment, and formulate and carry out the ideal treatment plan for each cat.
Dr. Matthew Oxford BVM&S GPCert(SAS) MRCVS, who helped develop the course, said: "Dentistry is poorly represented in undergraduate veterinary courses, with feline specific dentistry perhaps only having one or two lectures, yet dentistry accounts for roughly 25% of all general surgery.
"This transformational course uses a very practical approach to case management taking vets from the initial consultation, through anaesthesia, dental radiography, surgery, and then postoperative care.
"Cases are worked through with extensive teaching material supplemented into cases to provide a pragmatic, case-based approach.”
Pre-registration for the course is available until 1st November with an early bird price of £299 (+VAT) available using the discount code NEWCBL50 at the checkout.
For more information, to check eligibility and prerequisites, and to sign up, visit https://bit.ly/3GpFXo4
Tatiana graduated from the University of Trás-os-Montes e Alto Douro, Portugal in 2005.
She worked for more than 10 years in general practice in Portugal, where she dedicated most of her time to dermatology.
She started a three-year residency in 2016 at the at the Hospital Clinic Veterinari of the Fundació Universitat Autònoma de Barcelona and became a diplomate of the ECVD in 2020.
Tatiana’s appointment means NDSR will now offer a specialist-led dermatology service five days a week.
Tatiana said: “I am so excited to be a part of such an amazing multi-disciplinary hospital like NDSR.
“It’s not often that you come across hospitals which have all the equipment and services at hand to provide expert diagnosis to animals quickly and efficiently.
“My mission is to build on NDSR’s excellent service to primary care vets and pet owners in the region and hope that we can continue to act as a real extension of their teams.”
Gerry Polton, clinical director at NDSR, said: “Tatiana is clearly a very experienced and respected dermatologist and we are so pleased she has joined NDSR."
For more information, visit www.ndsr.co.uk/home.
The two organisations are collaborating to produce a topical monthly webinar with an expert speaker, supported with a collection of resources in the BSAVA library
Idexx is also offering a bursary scheme with 10 places on a BSAVA course of choice.
Dr Jason Johnson, Chief Medical Officer of Idexx said: "Continuous learning is an essential part of veterinary clinic life and an area that is increasing in demand, particularly with so many new and innovative ways to engage.
"Education enables veterinary professionals to provide better care for their patients and we are delighted to support them through our collaboration with BSAVA."
The first two ‘Topic of the month’ webinars will be on anaemia in cats and increased SDMA on pre-anaesthetic testing.
The webinars will be free of charge to all BSAVA members.
Sarah Fitzpatrick, Head of Partnerships and Events at the BSAVA said: “We are thrilled to be working with Idexx. It is increasingly important to us that our members receive accessible CPD, and through this valuable collaboration we are able to continue to support the veterinary profession.”
You can access the webinars through the BSAVA Library.
The survey was carried out to get an insight into how practices are currently helping clients ensure that their pets continue to enjoy life during their later years.
152 people took part: 60% nurses, 26% vets and 5% practice managers.
Less than 3 in 10 practices run senior pet clinics, and they mostly run them infrequently (biannually or less).
Three quarters of respondents also said that clients don't see the benefits of attending a senior pet clinic regularly.
It seems the current situation, then, is that few practices are providing a service that, er, apparently not many owners want.
Yet few in the profession would argue that a preventative approach is essential in order to give pets the best chance of leading healthier lives for longer.
To that end, Animalcare has produced some time-saving materials to help more practices run senior pet clinics, such as health check materials, handouts on age-related conditions and generic short articles for use in practice newsletters, which can be downloaded at: www.animalcare.co.uk/seniorpet
However, the problem is that these things alone cannot solve the underlying problem of a shortage of time.
The only way to solve that one is probably to find more inventive, efficient ways to engage with the owners of older pets in a way that minimise the time pressures on veterinary practice staff.
The company's new van has a range of 146 miles before it needs recharging, and it can be recharged to 80% within 40 minutes.
That puts 60% of MWI's customers within range of its distribution centre in Stoke-on-Trent, including those in Manchester and Birmingham.
As part of its drive to establish more sustainable operations, MWI has also launched a pilot with one of its corporate customers in which they reduce the number of deliveries made per week – adopting a two or three-day a week delivery system.
The company says that since January, that has resulted in 700,000 fewer vehicle miles.
In the study titled “Outcomes of treatments for keratomalacia in dogs and cats: a systematic review of the published literature including non-randomised controlled and non-controlled studies”, a systematic review of the current literature was undertaken to determine the evidence base for the various treatments of keratomalacia in dogs and cats.
The aim of the review was to assess the evidence base and identify recommended treatment(s) based on globe survival, visual outcome, and time to resolution (while maintaining a globe).
An online literature search found 18 relevant studies which were then reviewed and assigned a level of evidence base as described in the Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence Working Group.
Each study was assessed for type of study described (e.g. retrospective, prospective, controlled, random/non-random, cohort study, case series/study), the number of animals included, criteria for assessing outcome (e.g. vision, corneal clarity, anatomic repair) and duration of follow-up and time to resolution.
Systematic reviews of randomised trials, randomised trials or observational studies with dramatic effects would have provided the most reliable evidence on which to base recommendations for treatment(s) but none were available for inclusion.
Only one study was classified as level 3 evidence (non-randomised controlled trial) and considered the use of corneal cross-linking (CXL) in the treatment of keratomalacia.
Most studies were level four evidence reporting the outcome of a single treatment, with three prospective studies and seven retrospective studies.
The remaining seven studies were level five evidence (mechanism-based reasoning) and were considered not to provide good evidence for answering the particular study question.
The findings of the study suggest that the evidence for improved outcome of one proposed treatment over another proposed treatment for keratomalacia in dogs and/or cats is very weak.
A combination of treatments – both medical and surgical – may be the most appropriate depending on the individual case.
Studies utilising mechanism-based reasoning would suggest that medical treatment with anti-collagenase treatment is a minimum requirement for keratomalacia cases to prevent globe loss through perforation, with associated pain and suffering.
Nicola Di Girolamo, Editor of JSAP, said: “The findings of this study highlight once more the infrequency of randomised controlled trials in the veterinary literature, and the need for such studies to expand the evidence base in this field.
“Focussing on collecting available evidence in well-conducted systematic reviews is a critical step in order to improve accessibility of the literature for general practitioners and specialists alike.”
The full article can be found in the October issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13326. It is open access and can be freely accessed by anyone.
Photo courtesy BSAVA
The SPVS Salary Survey provides a benchmark of remuneration levels in the profession, including basic earnings, bonuses, dividends, overtime, accommodation, car allowances and pensions.
The main survey findings will be published in a report which will be shared with anyone who takes part and gives their email address at the end of the survey.
SPVS members will be given the full results with additional commentary and analysis.
The Association says all responses are treated as strictly anonymous and totally confidential, and thanks everyone in advance who decides to take part.
To take part, visit: https://spvs.org.uk/salary-survey-2021.
If you have any questions about the survey, email office@spvs.org.uk.
The survey asks EU nationals about their experience of practising in the UK since the referendum and will seek to find out what their career expectations and aspirations are now.
The survey will also ask how they feel that the RCVS has supported EU vets to practise in the UK since the transition period ended on 31 December 2020.
The survey is being conducted by the Institute for Employment Studies (IES), an independent, not-for-profit research institute.
Respondents are encouraged to be as open as possible, as individual responses will not be seen by the RCVS and all survey data will be analysed independently by IES.
Lizzie Lockett, RCVS CEO said: “We are hearing anecdotal feedback from EU veterinary professionals about the impact of the EU Exit on their working lives, but it is important for us to have direct feedback as evidence for our recommendations.
"I would encourage everyone who receives the survey to share their thoughts with us, as the feedback we receive from this and the previous surveys, will help us to plan what training, resources and support the professions need from us post-EU Exit."
Everyone eligible to take part in the survey is being sent an email today from Dilys Robinson at the IES, with a link to the survey.
You have until Tuesday 16th November 2021 to complete it.
If you have any questions, contact Sara.Butcher@employment-studies.co.uk.
The Association is also encouraging horse owners to join in the celebrations by sharing birthday cakes with their vet or veterinary practice.
BEVA President Huw Griffiths said: "Our 60 faces initiative celebrates some of the many outstanding people who have left an indelible mark on the profession and whose actions complement BEVA’s work in championing progress and/or diversity."
The list of 60 faces, which were nominated by BEVA members, showcases people who have inspired, influenced and progressed the equine veterinary profession for the better.
The faces range from 16th Century humanist Thomas Blundeville to 21st Century social media entrepreneur Ebony Escalona.
Every day for a month, two faces will be released on BEVA’s social media channels.
Huw added: “It was a really tough challenge to whittle the list down to 60 people as all of the nominees were exceptional individuals.
“The list showcases some of the best-known names in the industry as well as some heroes whose stories are less well known or who have been consigned to history.
“It’s not a “Top 60”, nor are all the faces vets, but it does highlight the breadth of people who have impacted what we do.
"We hope you will enjoy reading about them and we hope our lovely clients will join in the celebrations during the week starting 18th November by sharing a celebratory piece of birthday cake with their cherished horse vet!”
You can see the 60 Faces here: https://www.beva.org.uk/60-Faces
Ronnie (pictured right) will look at quality control and artefacts of sample quality and review the effects of different pathologies. By examining analyser output, he'll demonstrate how abnormalities of cells and plasma may affect measured parameters and their indices.
Using images, photomicrographs and video links, he'll move onto explain the techniques and equipment needed to complement analytical automation in order to confirm results quality.
Ronnie said: "“We now have more near patient testing in veterinary haematology than ever before. Quality is key to best practice and ultimately superior patient care. Sod’s Law states that ‘if something can go wrong, it will!’, so along the way to your generating a Complete Blood Count, it pays to be aware of some of the pitfalls that you may encounter.
“One should never underestimate the value of gross exam and simple methods that can be used to ensure sample quality and results accuracy. Seeing is believing after all!”
There will also be an open Q&A session with Ronnie after the presentation, so attendees are invited to bring any questions on all things haematology.
To register for the webinar, visit: https://register.gotowebinar.com/register/2458623866746094093
Colin graduated from the RVC in 1992 and has worked as a clinical veterinary surgeon in a variety of first opinion practices and referral centres. He trained as a veterinary anaesthetist at Bristol and Cambridge Universities before moving into the pharmaceutical industry, gaining experience in drug development and technical support, and pre- and post-marketing, at a number of companies.
Colin said: “Animalcare is introducing a number of new and innovative medicines, such as Daxocox, its weekly NSAID to reduce breakthrough pain in dogs with osteoarthritis, to the veterinary sector. This makes it an exciting environment in which to provide technical support.
“I’m looking forward to exploring how my experience can be most useful in supporting Animalcare’s expansion and, more importantly, ensuring that the company’s customers receive the guidance and advice they need to optimise the effectiveness of Animalcare’s product range in treating their patients.”
For technical support, email: technical@animalcare.co.uk
Rob Chapman, MD of the event organiser, CloserStill Media, said: "The London Vet Show in 2019 was the last major in-person event pre-Covid-19 pandemic
“We are delighted to be gathering once more. We had more tickets booked this September than any other year which has reinforced that there’s a real desire amongst the veterinary community to get back together and that confidence in events is returning.
"Our team is busy putting the final touches in place – including our new Covid-safety features, our speakers are excited to present to live audiences again, the delegates are making plans to see old friends. And, very importantly, our exhibitors are busy organising fantastic giveaways and getting stock ready. There has been so much fantastic R&D in the veterinary sector over the past two years and vet professionals will get to try it out first at the London Vet Show.”
BVA Senior Vice President, James Russell, said: “The London Vet Show is a highlight of the CPD and social calendar. The range of lectures we have on means there’s something for everybody – whether it’s clinical, non-clinical, BVA Congress or our career development stream. But the opportunity to see each other again after two years is something which I am so excited about.
"I know that there will be some people feeling nervous about the idea of coming together again. But one of the tremendous privileges I’ve had during the past year is being in London and watching it slowly unlock. I have to say that my recent experiences of being out and about in London make me feel very safe here.
"I do recognise that different people are at different points on their journey with that, but I hope that everyone finds a way of getting to the London Vet Show in a way they feel comfortable with. CloserStill have put in measures when we are there that will make us feel as safe and as comfortable as we can do.”
Professor Jill Maddison, who programmes the Royal Veterinary College Clinical’s small animal streams, said: “After almost two years I am beyond excited that we will be back together again at the London Vet Show. As usual we have a great line up of speakers from abroad, the RVC and around the UK who will deliver lectures covering many different aspects of clinical practice.
"I hope that whatever sessions you attend and whatever exhibits you visit at the 12th LVS you will find something to interest, intrigue and inspire you that you can take back to your practice to enhance the welfare of your patients and clients, your team and of course, yourself.”
Rob added: “We also have some fantastic new and returning features in store for delegates. For example, I’m delighted to announce the return of the popular Community Masterminds where online peers can meet in person and discuss topics that matter most to them.
"We are also hosting our very first Very Happy Hour on the exhibition floor from 5.30-6.45 pm on Day 1 where there will be drinks available for everyone to enjoy in a relaxed, spread-out fashion to celebrate being back together again.”
“We do ask that delegates planning on attending pre-register so we can best lay out the event and cater for the audience in a Covid-secure manner.”
One day and two-day tickets are available now. Register before Friday, 22nd October to receive your badge in the post. You can book at: https://london.vetshow.com/, call +44 (0)2476 719 687.
The interviews give an insight into the career advice the interviewees got from their school, what steps they took to secure their place to study for their qualification, what hurdles they had to overcome and what can be done to address issues around the under-representation of some groups within the profession.
The College says the aim is to help inspire school age children to consider a veterinary career through frank conversations with role models who have chosen a vet or vet nursing career.
The first film is an interview with Rheanna Ellis, a 2021 Nottingham Vet School graduate who is now working as a veterinary surgeon at a West Midlands practice. In her interview she talks about her passion to become a vet from a young age, how she went about researching and preparing for her job, and the importance of perseverance.
To help promote the videos and the College’s ongoing work on diversity and inclusion, the RCVS has partnered with the official Black History Month campaign and website which will also be hosting the videos.
Many of the interviews have been carried out by Mandisa Greene, RCVS Senior Vice-President, who helped lead the RCVS Black History Month activities last year as the College’s first ever black President.
Mandisa said: “It’s important that we demonstrate commitment to diversity and inclusion and have a role in acknowledging and accentuating diverse voices within the professions. Throughout these video interviews I’ve had the opportunity to speak to some inspiring newly qualified and student veterinary professionals who are all clearly very passionate about supporting animal health and welfare.
“I hope that school children from all backgrounds who watch these videos will get the chance to see how rewarding and enjoyable a veterinary career can be and that they’ll be inspired to consider becoming a vet or vet nurse in the future.”
The RCVS will be publishing more video interviews on its YouTube channel through October and beyond.
A graduate of Aristotle University of Thessaloniki, Greece Johnny went on to spend three years working as a general practitioner in England before starting a rotating internship at Queen’s Veterinary School Hospital, University of Cambridge.
Following a residency in Neurology and Neurosurgery at the Royal Veterinary College he was awarded the Diploma of the European College of Veterinary Neurology (ECVN) in 2014 and joined Davies in the same year.
Johnny has been Chairperson of the Education Committee of the ECVN College since 2018, has been the main author and co-author of numerous publications and regularly lectures in the UK and abroad.
Johnny said: “I am delighted to have been appointed to lead Davies’ neurology team to continue to build on the excellent reputation that we have established in neurology and neurosurgery over the past decade. Specialist and supportive care for neurological patients is paramount and we take pride in treating our patients as if they were our own pets.”